AnaCardio receives IND approval from the FDA for AC01 to Start a Clinical Pharmacology Study
Stockholm, Sweden, August 17, 2023 AnaCardio, a Swedish clinical-stage biopharmaceutical
Our latest news and insights
Stockholm, Sweden, August 17, 2023 AnaCardio, a Swedish clinical-stage biopharmaceutical
Solna, Sweden and Lugano, Switzerland, April 13, 2022 AnaCardio, a
Stockholm, Sweden, March 14 , 2023 AnaCardio´s founder Prof Lars
Stockholm, Sweden, November 17, 2022 AnaCardio today announces approval for
Stockholm, Sweden, September 7, 2022 AnaCardio raises SEK 150 million
Lugano, Switzerland and Stockholm, Sweden, February 3, 2022 Helsinn Group
Stockholm, Sweden, 3 February 2022 AnaCardio raises SEK 33 million
Stockholm Sweden – October 25, 2021 Karolinska Development’s portfolio company
Stockholm, Sweden, 22 October 2021 AnaCardio appoints Patrik Strömberg as
Stockholm, Sweden – June 17, 2021 Karolinska Development AB (Nasdaq
Feel free to contact us if you have any questions or want to book a meeting.
Contact us